FDA approves Crestor’s generic rivals, much to Astrazeneca’s dismay The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A Food and Drug Administration advisory panel recommended today that ...
MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries. Sun announced Wednesday the tentative approval of ...
Can we buy generic crestor 40 mg one day shipping Adjunct to diet in hypertriglyceridemia. Adjunct to diet in primary dysbetalipoproteinemia Type III hyperlipoproteinemia. Adjunct to diet to slow the ...
The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses: in combination with diet for the treatment of high ...
Pharmaceutical firm Actavis has reached an agreement with big pharma’s AstraZeneca to launch a generic version of the latter’s cholesterol-fighting drug Crestor in 2016. Actavis agreed to launch its ...
LONDON, Nov 1 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Thursday that Canada's Cobalt Pharmaceuticals was seeking U.S. regulatory permission to sell a generic version of its ...
Q. I just had a blood test, and my physician said my HDL cholesterol's low and my LDL is high -- the reverse of what it ought to be. She prescribed a brand-name statin drug, Crestor. When I asked ...
DIN: 10 mg tablet 20 mg tablet 40 mg tablet. Indication — as per As an adjunct to diet, at least equivalent to the Adult Treatment product monograph: Panel III ATP III TLC diet, for the reduction of ...
LONDON (Reuters) - AstraZeneca Plc said on Wednesday it had filed patent infringement actions in the United States against seven generic drugmakers, which have submitted plans to sell generic versions ...
(Reuters) - AstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for an upfront payment of $320 ...
The Food and Drug Administration is seeking to block an ad touting the safety of the cholesterol drug Crestor, calling the claims misleading. The agency asked the drug maker, AstraZeneca, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results